← FDA Drug Approvals (Drugs@FDA)

TIMOLOL MALEATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SENTISS PHARMA · Approved 2023-05-08

Drug application

FDA Application #

ANDA217195

Application type

Abbreviated New Drug Application (Generic)

Brand name

TIMOLOL MALEATE

Generic name

TIMOLOL MALEATE

Active ingredients

TIMOLOL MALEATE

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

SENTISS PHARMA

Manufacturer

Armas Pharmaceuticals, Inc.

First approval

2023-05-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown